This included the cancer type, sample size, interventions, control, treatment outcome, study type, detailed interventions, CD44 variants and isoforms, CD44 quantification, major findings, the effect of CD44 on chemotherapy outcome (e.g., overall survival, tumor recurrence, resistance to chemotherapy), and other cancer molecular biomarkers. Here, CD44 is linked to neoplasm.